- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Agfa moves to shed NDT business
Agfa-Gevaert will divest its nondestructive testing business group to GE Aircraft Engines. The transaction is pending the receipt of regulatory approvals. The NDT group, comprising more than 1000 employees, provides analog and digital x-ray and
Agfa-Gevaert will divest its nondestructive testing business group to GE Aircraft Engines. The transaction is pending the receipt of regulatory approvals. The NDT group, comprising more than 1000 employees, provides analog and digital x-ray and ultrasonic inspection systems to test the structure and tolerance of industrial materials. In 2002, Agfa's NDT customers in the aerospace, automotive, railway, energy, and petrochemical industries generated revenues of approximately Euro 220 million. These revenues represented about 4.5% of Agfa sales. The agreement with GE covers all Agfa NDT activities except the production of x-ray film, for which Agfa and GE have concluded a long-term supply agreement. Under this agreement, GE will become the exclusive distributor of Agfa industrial x-ray film.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
